David Cano-Rodriguez

TCTN2: a novel tumor marker with oncogenic properties

M. Rots, A. Pierleoni, G. Grandi, 2017, Oncotarget.

Re-expressing Epigenetically Silenced Genes by Inducing DNA Demethylation Through Targeting of Ten-Eleven Translocation 2 to Any Given Genomic Locus.

M. Rots, David Cano-Rodriguez, J. Rendón, 2017, Methods in molecular biology.

Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will

M. Rots, David Cano-Rodriguez, 2016, Current Genetic Medicine Reports.

Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner

M. Rots, M. Ruiters, Marianne G Rots, 2016, Nature Communications.

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

M. Rots, A. von Kriegsheim, Daniela Pankova, 2021, The EMBO journal.

RASSF1C oncogene elicits amoeboid invasion, cancer stemness and invasive EVs via a novel SRC/Rho axis

M. Rots, A. von Kriegsheim, Daniela Pankova, 2021, bioRxiv.

Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner

M. Rots, David Cano-Rodriguez, R. A. Gjaltema, 2016, Nature Communications.